Edwards Lifesciences (Irvine, California) reported completion early this month of a 20-year follow-up on the effectiveness and durability of its leading aortic pericardial tissue heart valve.
Browse by Speciality Area
All Access Subscription
Get unlimited access to our full publication and article library.
Get Access NowInterested in Group Sales? Learn more